Sensei Biotherapeutics/$FTH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sensei Biotherapeutics
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.
Ticker
$FTH
Sector
Primary listing
Employees
29
Headquarters
Website
FTH Metrics
BasicAdvanced
$22m
-
-$145.28
-0.23
-
Price and volume
Market cap
$22m
Beta
-0.23
52-week high
$36.76
52-week low
$6.18
Average daily volume
55k
Financial strength
Current ratio
14.393
Quick ratio
14.291
Total debt to equity
-0.757
Interest coverage (TTM)
-5,801.28%
Profitability
EBITDA (TTM)
-185.506
Management effectiveness
Return on assets (TTM)
-95.24%
Return on equity (TTM)
350.35%
Valuation
Price to book
-0.16
Price to tangible book (TTM)
-0.16
Price to free cash flow (TTM)
-0.877
Free cash flow yield (TTM)
-114.07%
Free cash flow per share (TTM)
-18.993
Growth
Earnings per share change (TTM)
529.36%
3-year earnings per share growth (CAGR)
68.91%
FTH News
AllArticlesVideos
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
Business Wire·3 days ago
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·2 weeks ago
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs